Clinical trial
The Effectiveness of Adding Pulsed Electromagnetic Field Therapy to a Tailored Exercise Program for Patients Suffering From Chemotherapy-induced Neuropathy Related to Breast Cancer: a Controlled, Double-blind Clinical Trial.
NCT06947577 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness of Adding Pulsed Electromagnetic Field Therapy to a Tailored Exercise Program for Patients Suffering From Chemotherapy-induced Neuropathy Related to Breast Cancer: a Controlled, Double-blind Clinical Trial.
- Lead sponsor
- Cairo University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- December 30, 2024
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuropathic